연구성과로 돌아가기

2024 연구자 정보 (21 / 1079)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 ⓘ 교신저자 여부 ⓘ Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Terashima, Masanori
(Terashima, M) ⓘ 		Shizuoka Canc Ctr, Div Gastr Surg, Shizuoka, Japan ⓘ
ⓘ
ⓘ 		[JCR상위 1.0] Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial ⓘ SCIE ⓘ 1.0 GASTROENTEROLOGY & HEPATOLOGY ⓘ msasako2010@yahoo.co.jp; ⓘ
Thanawala, Vaidehi
(Thanawala, V) ⓘ 		Vir Biotechnol, San Francisco, CA USA ⓘ
ⓘ
ⓘ 		[JCR상위 1.0] VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study ⓘ SCIE ⓘ 1.0 GASTROENTEROLOGY & HEPATOLOGY ⓘ mfyuen@hkucc.hku.hk; ⓘ
Woo, Yu Mi
(Woo, YM) ⓘ 		Kumoh Natl Inst Technol, Dept Mech Engn, Dept Aeronaut Mech & Elect Convergence Engn, 61 Daehak Ro, Gumi 39177, Gyeongbuk, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.0] Light-Material Interactions Using Laser and Flash Sources for Energy Conversion and Storage Applications ⓘ SCIE ⓘ 1.0 MATERIALS SCIENCE, MULTIDISCIPLINARY;NANOSCIENCE & NANOTECHNOLOGY;PHYSICS, APPLIED ⓘ kipark@knu.ac.kr;keonlee@kaist.ac.kr;jhryu@ynu.ac.kr; ⓘ
Yamada, Takanobu
(Yamada, T) ⓘ 		Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Yokohama, Japan ⓘ
ⓘ
ⓘ 		[JCR상위 1.0] Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial ⓘ SCIE ⓘ 1.0 GASTROENTEROLOGY & HEPATOLOGY ⓘ msasako2010@yahoo.co.jp; ⓘ
Yeh, Ta-Sen
(Yeh, TS) ⓘ 		Chang Gung Univ, Linkou Chang Gung Mem Hosp, Dept Surg, Taoyuan, Taiwan ⓘ
ⓘ
ⓘ 		[JCR상위 1.0] Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial ⓘ SCIE ⓘ 1.0 GASTROENTEROLOGY & HEPATOLOGY ⓘ msasako2010@yahoo.co.jp; ⓘ
Yoon, G.
(Yoon, G) ⓘ 		Natl Inst Math Sci, Daejeon 34047, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.0] THE IMPORTANCE OF PROVEN TREATMENT AS A VACCINE MODEL FOR COVID-19 ⓘ SCIE ⓘ 1.0 MATHEMATICS, APPLIED ⓘ sangil.kim@pusan.ac.kr; ⓘ
Yuen, Man-Fung
(Yuen, MF) ⓘ 		제1저자 교신저자 Univ Hong Kong, Sch Clin Med, Dept Med, Hong Kong, Peoples R China
Univ Hong Kong, Dept Microbiol, Hong Kong, Special Adm Reg, Peoples R China ⓘ 		C-4466-2009
Yuen, Richard Man Fung ⓘ
ⓘ 		[JCR상위 1.0] VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study ⓘ SCIE ⓘ 1.0 GASTROENTEROLOGY & HEPATOLOGY ⓘ mfyuen@hkucc.hku.hk; ⓘ
Zhang, Tiandong
(Zhang, TD) ⓘ 		Harbin Univ Sci & Technol, Sch Elect & Elect Engn, Harbin 150080, Peoples R China
Harbin Univ Sci & Technol, Key Lab Engn Dielect & Its Applicat, Minist Educ, Harbin 150080, Peoples R China ⓘ
ⓘ
ⓘ 		[JCR상위 1.0] Light-Material Interactions Using Laser and Flash Sources for Energy Conversion and Storage Applications ⓘ SCIE ⓘ 1.0 MATERIALS SCIENCE, MULTIDISCIPLINARY;NANOSCIENCE & NANOTECHNOLOGY;PHYSICS, APPLIED ⓘ kipark@knu.ac.kr;keonlee@kaist.ac.kr;jhryu@ynu.ac.kr; ⓘ
Aguilar, C. Orbegoso
(Aguilar, CO) ⓘ 		Daiichi Sankyo Inc, Dept Global Oncol R&D, Rueil Malmaison, France ⓘ
ⓘ
ⓘ 		[JCR상위 1.1] Exploratory biomarker analysis of trastuzumab deruxtecan versus treatment of physician's choice in HER2-low, hormone receptorepositive metastatic breast cancer in DESTINY-Breast04 ⓘ SCIE ⓘ 1.1 ONCOLOGY ⓘ ⓘ
Al-Ahmadie, H.
(Al-Ahmadie, H) ⓘ 		Mem Sloan Kettering Canc Ctr, Dept Pathol & Lab Med, New York, NY USA ⓘ
ⓘ
ⓘ 		[JCR상위 1.1] A randomized phase III trial of neoadjuvant durvalumab plus chemotherapy followed by radical cystectomy and adjuvant durvalumab in muscle-invasive bladder cancer (NIAGARA) ⓘ SCIE ⓘ 1.1 ONCOLOGY ⓘ ⓘ
Alam, Md Badrul
(Alam, MB) ⓘ 		Kyungpook Natl Univ, Grad Sch, Dept Food Sci & Biotechnol, Daegu 41566, South Korea
Kyungpook Natl Univ, Food & Bioind Res Inst, Inner Beauty Antiaging Ctr, Daegu 41566, South Korea
Kyungpook Natl Univ, Grad Sch, Dept Food Sci & Biotechnol, Daegu, South Korea
Kyungpook Natl Univ, Food & Bioind Res Inst, Inner Beauty Antiaging Ctr, Daegu, South Korea ⓘ 		AFL-7668-2022
AAK-7176-2021
Alam, Md Badrul ⓘ 		0000-0002-8509-6827
ALAM, MD BADRUL ⓘ 		[JCR상위 1.1] γ-Mangosteen, an autophagy enhancer, prevents skin-aging via activating KEAP1/NRF2 signaling and downregulating MAPKs/AP-1/ NF-κB-mediated MMPs
[JCR상위 5.9] Glycoprotein from Sargassum fusiforme exhibiting anti-inflammatory responses in vitro and in vivo via modulation of TLR4/MyD88 and NF-κB signaling
[JCR상위 33.2] Biological activities, identification, method development, and validation for analysis of polyphenolic compounds in Nymphaea rubra flowers and leaves by UHPLC-Q-cIM-TOF-MS and UHPLC-TQ-MS
[JCR상위 10.4] RSM- and ANN-Based Multifrequency Ultrasonic Extraction of Polyphenol-Rich Sargassum horneri Extracts Exerting Antioxidative Activity via the Regulation of MAPK/Nrf2/HO-1 Machinery
[JCR상위 10.3] Development of a rapid screening method utilizing 2D LC for effect-directed analysis in the identification of environmental toxicants
[JCR상위 10.4] Optimization, Metabolomic Analysis, Antioxidant Potential and Depigmenting Activity of Polyphenolic Compounds from Unmature Ajwa Date Seeds (Phoenix dactylifera L.) Using Ultrasonic-Assisted Extraction
[JCR상위 10.7] Glutamic-Alanine Rich Glycoprotein from Undaria pinnatifida: A Promising Natural Anti-Inflammatory Agent ⓘ 		SCIE ⓘ 1.1 CHEMISTRY, MEDICINAL;INTEGRATIVE & COMPLEMENTARY MEDICINE;PHARMACOLOGY & PHARMACY;PLANT SCIENCES
BIOCHEMISTRY & MOLECULAR BIOLOGY;CHEMISTRY, APPLIED;POLYMER SCIENCE
BIOCHEMICAL RESEARCH METHODS;CHEMISTRY, ANALYTICAL;PLANT SCIENCES
BIOCHEMISTRY & MOLECULAR BIOLOGY;CHEMISTRY, MEDICINAL;FOOD SCIENCE & TECHNOLOGY
ENVIRONMENTAL SCIENCES
CHEMISTRY, MEDICINAL;PHARMACOLOGY & PHARMACY ⓘ 		sang@knu.ac.kr;
sang@knu.ac.kr;sunghwank@knu.ac.kr;
ahsanjaved@knu.ac.kr;mbalam@knu.ac.kr;naznin@knu.ac.kr;ahmed@knu.ac.kr;changhyung@snu.ac.kr;sunghwank@knu.ac.kr;sang@knu.ac.kr;
sunghwank@knu.ac.kr;
alfnar744@gmail.com;mbalam@knu.ac.kr;naznin@knu.ac.kr;sunghwank@knu.ac.kr;sang@knu.ac.kr;
md-saifur.rahman.1@ulaval.ca;mbalam@knu.ac.kr;naznin@knu.ac.kr;mosammad-hur.madina.1@ulaval.ca;rafiquzzaman@bsmrau.edu.bd; ⓘ
Antonuzzo, L.
(Antonuzzo, L) ⓘ 		Univ Careggi, Azienda Osped, SODc Oncol Med, Florence, Italy ⓘ
ⓘ
ⓘ 		[JCR상위 1.1] A randomized phase III trial of neoadjuvant durvalumab plus chemotherapy followed by radical cystectomy and adjuvant durvalumab in muscle-invasive bladder cancer (NIAGARA) ⓘ SCIE ⓘ 1.1 ONCOLOGY ⓘ ⓘ
Armstrong, J.
(Armstrong, J) ⓘ 		AstraZeneca, Stat, Cambridge, England ⓘ
ⓘ
ⓘ 		[JCR상위 1.1] A randomized phase III trial of neoadjuvant durvalumab plus chemotherapy followed by radical cystectomy and adjuvant durvalumab in muscle-invasive bladder cancer (NIAGARA) ⓘ SCIE ⓘ 1.1 ONCOLOGY ⓘ ⓘ
Atduev, V.
(Atduev, V) ⓘ 		Fed Med Biol Agcy, Volga Dist Med Ctr, Nizhnii Novgorod, Russia ⓘ
ⓘ
ⓘ 		[JCR상위 1.1] A randomized phase III trial of neoadjuvant durvalumab plus chemotherapy followed by radical cystectomy and adjuvant durvalumab in muscle-invasive bladder cancer (NIAGARA) ⓘ SCIE ⓘ 1.1 ONCOLOGY ⓘ ⓘ
Ba, Y.
(Ba, Y) ⓘ 		TMUCIH Tianjin Med Univ Canc Inst & Hosp, Dept GI Med Oncol, Tianjin, Peoples R China ⓘ
ⓘ
ⓘ 		[JCR상위 1.1] Real-world treatment (Tx) patterns in patients (pts) with HER2-positive locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma (HER2+aGC/GEJC) in East Asia (HER2+GASTA) ⓘ SCIE ⓘ 1.1 ONCOLOGY ⓘ ⓘ
페이지 이동: